Dr. Karyn A. Goodman, MD

Dr. Goodman practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Goodman's NPI, 1275670671, was assigned on February 1, 2007. Dr. Goodman graduated from Stanford University School Of Medicine in 1999. Dr. Goodman's California license number on file is 219411-1.

Dr. Goodman's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Goodman also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Goodman's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Goodman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goodman practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Goodman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Goodman is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Goodman's licenses on file in 3 states: California, New York and Colorado.

Dmand AI lists anal cancer radiation, bone cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and pancreatic cancer radiation among the conditions Dr. Goodman treats.

CMS data shows 281 Medicare services from Dr. Goodman across 10 procedure codes in 2024, for 49 Medicare patients. Medicare paid $28,972 for them.

CMS counts 49 Medicare patients who saw Dr. Goodman in 2024. The largest group is 75 to 84, with 21 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goodman's median patient age at 69, with 49% women.

In 2024, Dr. Goodman wrote 33 Medicare Part D claims for 14 patients. 85% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $1,598 in total drug cost. In 2021, CMS named 27 claims across 2 drugs.

Dr. Goodman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goodman as offering telehealth.

Dmand AI links 166 papers to Dr. Goodman, published from 2008 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Pancreatic Neoplasms, Adenocarcinoma and Radiosurgery. Dr. Goodman has published most often in Int J Radiat Oncol Biol Phys. Dr. Goodman's most frequent co-authors are Abraham Jing-Ching Wu, MD, Martin R. Weiser, MD and Philip B. Paty, MD.

Dmand AI links Dr. Goodman to 7 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Adenocarcinoma Of Esophagus, Anus Neoplasms and Bile Duct Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 2.

CMS Open Payments shows 22 general payments to Dr. Goodman from 12 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 84% of the total. Merck Sharp & Dohme Corporation paid the most, $5,006. It also lists 1 research payment totaling $1,016 in 2022.

Dmand AI lists 1 award for Dr. Goodman, most recently Top Doctors: New York Metro Area in 2014.

Dr. Goodman graduated from Stanford University School Of Medicine in 1999. Dr. Goodman is a member of ASCO.

Dr. Goodman is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.